№ files_lp_4_process_2_73548
Preclinical research article detailing the characterization, cytotoxicity, and target-specific activity of the TROP2-directed antibody–drug conjugate OBI-992 across various in vitro and in vivo cancer models.
Year: 2026
Type of document: Research article / Supplemental methods
Subject: Oncology, antibody–drug conjugates
Authors: Wan-Fen Li, Ming-Feng Chiang, Hao-Cheng Weng, Jhih-Jie Yang, Hsin-Shan Wu, Szu-Yu Wu, Yu-Jung Chen, Chi‐Huan Lu, Jyy-Shiuan Tu, Ren-Yu Hsu, Chi-Sheng Shia, Teng-Yi Huang, Ming-Tain Lai
Affiliation: Various research institutions (detailed in original publication)
Experimental models: Multiple human and murine cancer cell lines, PDX models
Key molecules studied: OBI-992, exatecan, Dato-DXd
Assays performed: Hydrophobic interaction chromatography, RPLC-UV, LC/MS/MS, flow cytometry, ELISA, ATP measurement, RNA-seq
Cell lines: NCI-N87, BxPC3, HCC827, NCI-H1975, MDA-MB-231, Capan-1, ES-2/GFP, MC38, HCC827/ABCB1, HCC827/ABCG2, Caco-2
Key outcomes measured: DAR distribution, IC50 values, TROP2 expression, immunogenic cell death markers, ABC transporter expression
Data sources: Crown Bioscience, WuXi Biologics, Human Protein Atlas
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.